×

Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation

  • US 10,208,050 B2
  • Filed: 08/04/2017
  • Issued: 02/19/2019
  • Est. Priority Date: 07/12/2007
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating a CCR2-mediated condition or disease, comprising administering to a subject a therapeutically effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof:

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×